Elite Laboratories, Inc   Report issue

For profit Phase 3
Founded: Northvale NJ United States (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2015
NCT02391571
First Marketed Drug
1997
phentermine (wyamine)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ELITE | ELITE LABS | ELITE LABS INC | ELITE PHARM SOLUTION